Zobrazeno 1 - 10
of 858
pro vyhledávání: '"Futran A"'
Autor:
Cassie Pan, Kevin Ng, Jenna Voutsinas, Brittany Barber, Zain H. Rizvi, Emily Marchiano, Rocco M. Ferrandino, Neal Futran, George E. Laramore, Jay J. Liao, Upendra Parvathaneni, Neil Panjwani, Renato G. Martins, Cristina P. Rodriguez, Qian “Vicky” Wu
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background We previously reported in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with immune checkpoint inhibitors (ICIs), pretreatment higher lactate dehydrogenase (LDH) and absolute (abx) neutrophils as w
Externí odkaz:
https://doaj.org/article/bfd40bb3c54a46b189444a35cea48f00
Publikováno v:
Laryngoscope Investigative Otolaryngology, Vol 8, Iss 6, Pp 1500-1506 (2023)
Abstract Objectives Margin status interpretation following transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma (OPSCC) is challenging. This study aims to assess the discrepancy between status of margins as reported by the patho
Externí odkaz:
https://doaj.org/article/d489547b10ff425abed34d647380e524
Autor:
Alan S. Futran, Tao Lu, Katherine Amberg-Johnson, Jiayi Xu, Xiaoxiao Yang, Saidi He, Sarah Boyce, Jeffrey A. Bell, Robert Pelletier, Takao Suzuki, Xianhai Huang, Heng Qian, Liping Fang, Li Xing, Zhaowu Xu, Stephen E. Kurtz, Jeffrey W. Tyner, Wayne Tang, Tao Guo, Karen Akinsanya, David Madge, Kristian K. Jensen
Publikováno v:
iScience, Vol 27, Iss 5, Pp 109693- (2024)
Summary: The USP7 deubiquitinase regulates proteins involved in the cell cycle, DNA repair, and epigenetics and has been implicated in cancer progression. USP7 inhibition has been pursued for the development of anti-cancer therapies. Here, we describ
Externí odkaz:
https://doaj.org/article/ad0bc59a163a477bae0474b6a3ff6a2d
Autor:
Futran, Alan S., Lu, Tao, Amberg-Johnson, Katherine, Xu, Jiayi, Yang, Xiaoxiao, He, Saidi, Boyce, Sarah, Bell, Jeffrey A., Pelletier, Robert, Suzuki, Takao, Huang, Xianhai, Qian, Heng, Fang, Liping, Xing, Li, Xu, Zhaowu, Kurtz, Stephen E., Tyner, Jeffrey W., Tang, Wayne, Guo, Tao, Akinsanya, Karen, Madge, David, Jensen, Kristian K.
Publikováno v:
In iScience 17 May 2024 27(5)
Autor:
Franklin M. Wu, Daniel Gorelik, Michael J. Brenner, Masayoshi Takashima, Amit Goyal, Ashley E. Kita, Austin S. Rose, Robert S. Hong, Waleed M. Abuzeid, Peter Santa Maria, Ahmed A. Al‐Sayed, Michael E. Dunham, Prajoy Kadkade, Scott R. Schaffer, Alan W. Johnson, Adrien A. Eshraghi, Shireen Samargandy, Robert J. Morrison, Philip A. Weissbrod, Margaret B. Mitchell, Cyrus C. Rabbani, Neil Futran, Omar G. Ahmed
Publikováno v:
OTO Open, Vol 8, Iss 1, Pp n/a-n/a (2024)
Abstract Objective To review new drugs and devices relevant to otolaryngology approved by the Food and Drug Administration (FDA) in 2022. Data Sources Publicly available FDA data on drugs and devices approved in 2022. Review Methods A preliminary scr
Externí odkaz:
https://doaj.org/article/de80a9a3268347119103da77748f3807
Autor:
Cassie Pan, Qian Vicky Wu, Jenna Voutsinas, Jeffrey J. Houlton, Brittany Barber, Zain H. Rizvi, Emily Marchiano, Neal Futran, George E. Laramore, Jay J. Liao, Upendra Parvathaneni, Renato G. Martins, Jonathan R. Fromm, Cristina P. Rodriguez
Publikováno v:
Cancer Medicine, Vol 12, Iss 8, Pp 9384-9391 (2023)
Abstract Background Little is known regarding associations between peripheral blood biomarkers (PBBMs) and survival, response, and toxicity in recurrent/metastatic head and neck squamous cell carcinomas (R/M HNSCC) treated with immune checkpoint inhi
Externí odkaz:
https://doaj.org/article/abf9f7ebd9ed41ab997ecff27e40bfec
Autor:
Joey Seuferling, BS, Alex Diaz, MD, Neal Futran, MD, DMD, Anshu Bandhlish, MD, Pattana Wangaryattawanich, MD
Publikováno v:
Radiology Case Reports, Vol 18, Iss 2, Pp 519-523 (2023)
The aim of this case report is to demonstrate a case of primary thyroid hemangioma in a 62-year-old female who presented with a painless neck mass, treated with right hemithyroidectomy and diagnosed by surgical biopsy. Thyroid hemangiomas are rare, b
Externí odkaz:
https://doaj.org/article/8e6df9d41eb84bee8bdcaef0362e1528
Autor:
Cameron Chalker, Jenna M. Voutsinas, Qian Vicky Wu, Rafael Santana‐Davila, Victoria Hwang, Christina S. Baik, Sylvia Lee, Brittany Barber, Neal D. Futran, Jeffrey J. Houlton, George E. Laramore, Jay Justin Liao, Upendra Parvathaneni, Renato G. Martins, Keith D. Eaton, Cristina P. Rodriguez
Publikováno v:
Cancer Medicine, Vol 11, Iss 22, Pp 4104-4111 (2022)
Abstract Background Anti‐PD1 checkpoint inhibitors (ICI) represent an established standard‐of‐care for patients with recurrent/metastatic head and neck squamous cell carcinoma (RMHNSCC). Landmark studies excluded patients with ECOG performance
Externí odkaz:
https://doaj.org/article/53da6a9d3e554131937be881d3ebe09e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.